Bolt Biotherapeutics, Inc. (BOLT) vs Enlivex Therapeutics Ltd. (ENLV)

A side-by-side comparison of Bolt Biotherapeutics, Inc. and Enlivex Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BOLT vs ENLV

growth of $100 · dividends reinvested · last 6y
BOLT -99.5% (-58.1%/yr)ENLV -99.8% (-66.0%/yr)BOLT compounded faster over this window
050100Start $10020222023202420252026$1$0
BOLT ENLV

BOLT vs ENLV: by the numbers

  • •BOLT is the larger company ($7M vs $6M market cap).
  • •Both run net losses; ENLV's is the smaller (0.00% vs -611.47% net margin).

Metrics side by side

Valuation

MetricBOLTENLV
P/E ratioN/A0.00
P/S ratio1.46N/A
P/B ratio0.540.00

Profitability

MetricBOLTENLV
Gross margin80.62%0.00%
Operating margin-450.07%0.00%
Net margin-611.47%0.00%
ROE-227.37%105.35%
ROIC-90.17%-0.32%

Growth (annualized)

MetricBOLTENLV
Total return CAGR (5Y)-57.61%-69.81%

Frequently asked

How have BOLT and ENLV total returns compared?
Over the past 5 years, BOLT delivered -57.61% and ENLV delivered -69.81% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.